A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)

NCT04104321 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

157

Enrollment

INDUSTRY

Sponsor class

Stopped Interim analysis results from the open-label part of the study. The double blind portion of the study will be resumed once the study will continue.

Conditions

Nonalcoholic Steatohepatitis (NASH)

Interventions

DRUG: Aramchol free acid
DRUG: Placebo

Sponsor

Galmed Research and Development, Ltd.